(Q38089284)

28 August 2017

title

The use of insulin analogues in pregnancy (English)

1 reference

28 August 2017

1 reference

K Lambert

1

1 reference

28 August 2017

R I G Holt

series ordinal

2

1 reference

28 August 2017

publication date

9 April 2013

1 reference

Diabetes, Obesity and Metabolism

28 August 2017

published in

1 reference

28 August 2017

volume

15

1 reference

28 August 2017

issue

10

1 reference

28 August 2017

page(s)

888-900

1 reference

Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands

28 August 2017

cites work

1 reference

Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study

21 January 2018

1 reference

Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study

21 January 2018

1 reference

Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy

21 January 2018

1 reference

Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy

21 January 2018

1 reference

Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development--Diabetes in Early Pregnancy Study

21 January 2018

1 reference

Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: A randomized controlled clinical trial

21 January 2018

1 reference

Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy.

21 January 2018

1 reference

Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control

21 January 2018

1 reference

A bihormonal closed-loop artificial pancreas for type 1 diabetes

21 January 2018

1 reference

Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review

21 January 2018

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellit

21 January 2018

1 reference

Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy.

21 January 2018

1 reference

Diabetes in pregnancy 1985.

21 January 2018

1 reference

Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects

21 January 2018

1 reference

Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.

21 January 2018

1 reference

Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study

21 January 2018

1 reference

Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus

21 January 2018

1 reference

Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus

21 January 2018

1 reference

Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study.

21 January 2018

1 reference

Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy

21 January 2018

1 reference

Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog).

21 January 2018

1 reference

Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes

21 January 2018

1 reference

Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience.

21 January 2018

1 reference

Is insulin lispro safe in pregnant women: Does it cause any adverse outcomes on infants or mothers?

21 January 2018

1 reference

Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus

21 January 2018

1 reference

Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro

21 January 2018

1 reference

Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women

21 January 2018

1 reference

Metabolic and immunologic effects of insulin lispro in gestational diabetes

21 January 2018

1 reference

Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy

21 January 2018

1 reference

Survey of glargine use in 115 pregnant women with Type 1 diabetes

21 January 2018

1 reference

Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes

21 January 2018

1 reference

Perinatal outcomes associated with the use of glargine during pregnancy

21 January 2018

1 reference

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study

21 January 2018

1 reference

Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy

21 January 2018

1 reference

IGF-1 in gynaecology and obstetrics: update 2002.

21 January 2018

1 reference

Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes

21 January 2018

1 reference

Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes

21 January 2018

1 reference

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

21 January 2018

1 reference

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

21 January 2018

1 reference

Audit of insulin detemir in pregnancy: a retrospective case series

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DOM.12098

1 reference

28 August 2017

1 reference